Shawn Novick has worked in the biotherapeutic field for over 30 years. She spent the first half of her career in analytical sciences, characterizing products for clinical and commercial approval including a number of cytokines, monoclonal antibodies, Fc-fusion proteins and protein conjugates. The second half of her career she was the Sr. Director of Quality Control at Seattle Genetics, where she built a Quality group from 4 to 50 analysts, working on an array of antibody drug conjugates. Shawn has contributed to a number of commercial products including Enbrel, Leukine, Bexxar, and Adcetris. She has written or edited multiple regulatory submissions and worked on successful CMC strategies for multiple products.

In addition to her day job, Shawn has organized and co-chaired workshops and conferences, including the annual WCBP conference held in Washington D.C. which brings together over 800 regulators and biotherapeutics professions for 3 days of close interaction. Shawn has published and presented on protein characterization and specification management and currently is consulting for biotechnology companies. She lives in Seattle, Washington.